Decreased benzodiazepine receptor and increased GABA level in cortical tubers in tuberous sclerosis complex
To elucidate the functional characteristics of cortical tubers that might be responsible for epilepsy in tuberous sclerosis complex (TSC), proton magnetic resonance spectroscopy (1H-MRS) and [123I] iomazenil (123I-IMZ) single photon emission computed tomography (SPECT) were performed. 1H-MRS using a...
Saved in:
Published in | Brain & development (Tokyo. 1979) Vol. 34; no. 6; pp. 478 - 486 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.06.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | To elucidate the functional characteristics of cortical tubers that might be responsible for epilepsy in tuberous sclerosis complex (TSC), proton magnetic resonance spectroscopy (1H-MRS) and [123I] iomazenil (123I-IMZ) single photon emission computed tomography (SPECT) were performed.
1H-MRS using a clinical 3-tesla magnetic resonance imager was performed in four children with TSC and 10 age-and sex-matched healthy control subjects. A single voxel was set on the right parietal lobe in control subjects. In patients with TSC, a single voxel was set on the epileptogenic tuber in the parietal or temporal lobe, and another voxel was set on the contralateral normal-appearing brain region. N-Acetylaspartate (NAA), myo-Inositol (mIns) and Glutamate (Glu) were analyzed using a conventional STEAM (Stimulated Echo Acquisition Mode) method. The concentration of gamma-aminobutyric acid (GABA) was quantified using MEGA-Point Resolved Spectroscopy (PRESS). Interictal 123I-IMZ SPECT was examined in all four patients with TSC.
A significant decrease in the NAA concentration and significant increases in the mIns and GABA concentrations were detected in the cortical tubers of all 4 patients. No significant difference was observed in Glu concentrations. In all of the cortical tubers detected by magnetic resonance imaging, 123I-IMZ binding was significantly decreased.
Epileptogenesis in TSC might be caused by decreased inhibition secondary to the decrease in GABA receptors in dysplastic neurons of cortical tubers. An increase in the GABA concentration may compensate for decreased inhibition. |
---|---|
AbstractList | To elucidate the functional characteristics of cortical tubers that might be responsible for epilepsy in tuberous sclerosis complex (TSC), proton magnetic resonance spectroscopy ((1)H-MRS) and [123I] iomazenil (123I-IMZ) single photon emission computed tomography (SPECT) were performed.PURPOSETo elucidate the functional characteristics of cortical tubers that might be responsible for epilepsy in tuberous sclerosis complex (TSC), proton magnetic resonance spectroscopy ((1)H-MRS) and [123I] iomazenil (123I-IMZ) single photon emission computed tomography (SPECT) were performed.(1)H-MRS using a clinical 3-tesla magnetic resonance imager was performed in four children with TSC and 10 age-and sex-matched healthy control subjects. A single voxel was set on the right parietal lobe in control subjects. In patients with TSC, a single voxel was set on the epileptogenic tuber in the parietal or temporal lobe, and another voxel was set on the contralateral normal-appearing brain region. N-Acetylaspartate (NAA), myo-Inositol (mIns) and Glutamate (Glu) were analyzed using a conventional STEAM (Stimulated Echo Acquisition Mode) method. The concentration of gamma-aminobutyric acid (GABA) was quantified using MEGA-Point Resolved Spectroscopy (PRESS). Interictal 123I-IMZ SPECT was examined in all four patients with TSC.METHODS(1)H-MRS using a clinical 3-tesla magnetic resonance imager was performed in four children with TSC and 10 age-and sex-matched healthy control subjects. A single voxel was set on the right parietal lobe in control subjects. In patients with TSC, a single voxel was set on the epileptogenic tuber in the parietal or temporal lobe, and another voxel was set on the contralateral normal-appearing brain region. N-Acetylaspartate (NAA), myo-Inositol (mIns) and Glutamate (Glu) were analyzed using a conventional STEAM (Stimulated Echo Acquisition Mode) method. The concentration of gamma-aminobutyric acid (GABA) was quantified using MEGA-Point Resolved Spectroscopy (PRESS). Interictal 123I-IMZ SPECT was examined in all four patients with TSC.A significant decrease in the NAA concentration and significant increases in the mIns and GABA concentrations were detected in the cortical tubers of all 4 patients. No significant difference was observed in Glu concentrations. In all of the cortical tubers detected by magnetic resonance imaging, 123I-IMZ binding was significantly decreased.RESULTSA significant decrease in the NAA concentration and significant increases in the mIns and GABA concentrations were detected in the cortical tubers of all 4 patients. No significant difference was observed in Glu concentrations. In all of the cortical tubers detected by magnetic resonance imaging, 123I-IMZ binding was significantly decreased.Epileptogenesis in TSC might be caused by decreased inhibition secondary to the decrease in GABA receptors in dysplastic neurons of cortical tubers. An increase in the GABA concentration may compensate for decreased inhibition.CONCLUSIONEpileptogenesis in TSC might be caused by decreased inhibition secondary to the decrease in GABA receptors in dysplastic neurons of cortical tubers. An increase in the GABA concentration may compensate for decreased inhibition. To elucidate the functional characteristics of cortical tubers that might be responsible for epilepsy in tuberous sclerosis complex (TSC), proton magnetic resonance spectroscopy ((1)H-MRS) and [123I] iomazenil (123I-IMZ) single photon emission computed tomography (SPECT) were performed. (1)H-MRS using a clinical 3-tesla magnetic resonance imager was performed in four children with TSC and 10 age-and sex-matched healthy control subjects. A single voxel was set on the right parietal lobe in control subjects. In patients with TSC, a single voxel was set on the epileptogenic tuber in the parietal or temporal lobe, and another voxel was set on the contralateral normal-appearing brain region. N-Acetylaspartate (NAA), myo-Inositol (mIns) and Glutamate (Glu) were analyzed using a conventional STEAM (Stimulated Echo Acquisition Mode) method. The concentration of gamma-aminobutyric acid (GABA) was quantified using MEGA-Point Resolved Spectroscopy (PRESS). Interictal 123I-IMZ SPECT was examined in all four patients with TSC. A significant decrease in the NAA concentration and significant increases in the mIns and GABA concentrations were detected in the cortical tubers of all 4 patients. No significant difference was observed in Glu concentrations. In all of the cortical tubers detected by magnetic resonance imaging, 123I-IMZ binding was significantly decreased. Epileptogenesis in TSC might be caused by decreased inhibition secondary to the decrease in GABA receptors in dysplastic neurons of cortical tubers. An increase in the GABA concentration may compensate for decreased inhibition. To elucidate the functional characteristics of cortical tubers that might be responsible for epilepsy in tuberous sclerosis complex (TSC), proton magnetic resonance spectroscopy (1H-MRS) and [123I] iomazenil (123I-IMZ) single photon emission computed tomography (SPECT) were performed. 1H-MRS using a clinical 3-tesla magnetic resonance imager was performed in four children with TSC and 10 age-and sex-matched healthy control subjects. A single voxel was set on the right parietal lobe in control subjects. In patients with TSC, a single voxel was set on the epileptogenic tuber in the parietal or temporal lobe, and another voxel was set on the contralateral normal-appearing brain region. N-Acetylaspartate (NAA), myo-Inositol (mIns) and Glutamate (Glu) were analyzed using a conventional STEAM (Stimulated Echo Acquisition Mode) method. The concentration of gamma-aminobutyric acid (GABA) was quantified using MEGA-Point Resolved Spectroscopy (PRESS). Interictal 123I-IMZ SPECT was examined in all four patients with TSC. A significant decrease in the NAA concentration and significant increases in the mIns and GABA concentrations were detected in the cortical tubers of all 4 patients. No significant difference was observed in Glu concentrations. In all of the cortical tubers detected by magnetic resonance imaging, 123I-IMZ binding was significantly decreased. Epileptogenesis in TSC might be caused by decreased inhibition secondary to the decrease in GABA receptors in dysplastic neurons of cortical tubers. An increase in the GABA concentration may compensate for decreased inhibition. Abstract Purpose To elucidate the functional characteristics of cortical tubers that might be responsible for epilepsy in tuberous sclerosis complex (TSC), proton magnetic resonance spectroscopy (1 H-MRS) and [123I] iomazenil (123I-IMZ) single photon emission computed tomography (SPECT) were performed. Methods1 H-MRS using a clinical 3-tesla magnetic resonance imager was performed in four children with TSC and 10 age-and sex-matched healthy control subjects. A single voxel was set on the right parietal lobe in control subjects. In patients with TSC, a single voxel was set on the epileptogenic tuber in the parietal or temporal lobe, and another voxel was set on the contralateral normal-appearing brain region. N -Acetylaspartate (NAA), myo-Inositol (mIns) and Glutamate (Glu) were analyzed using a conventional STEAM (Stimulated Echo Acquisition Mode) method. The concentration of gamma-aminobutyric acid (GABA) was quantified using MEGA-Point Resolved Spectroscopy (PRESS). Interictal 123I-IMZ SPECT was examined in all four patients with TSC. Results A significant decrease in the NAA concentration and significant increases in the mIns and GABA concentrations were detected in the cortical tubers of all 4 patients. No significant difference was observed in Glu concentrations. In all of the cortical tubers detected by magnetic resonance imaging, 123I-IMZ binding was significantly decreased. Conclusion Epileptogenesis in TSC might be caused by decreased inhibition secondary to the decrease in GABA receptors in dysplastic neurons of cortical tubers. An increase in the GABA concentration may compensate for decreased inhibition. Purpose: To elucidate the functional characteristics of cortical tubers that might be responsible for epilepsy in tuberous sclerosis complex (TSC), proton magnetic resonance spectroscopy (1H-MRS) and [123I] iomazenil (123I-IMZ) single photon emission computed tomography (SPECT) were performed. Methods: 1H-MRS using a clinical 3-tesla magnetic resonance imager was performed in four children with TSC and 10 age-and sex-matched healthy control subjects. A single voxel was set on the right parietal lobe in control subjects. In patients with TSC, a single voxel was set on the epileptogenic tuber in the parietal or temporal lobe, and another voxel was set on the contralateral normal-appearing brain region. N-Acetylaspartate (NAA), myo-Inositol (mIns) and Glutamate (Glu) were analyzed using a conventional STEAM (Stimulated Echo Acquisition Mode) method. The concentration of gamma-aminobutyric acid (GABA) was quantified using MEGA-Point Resolved Spectroscopy (PRESS). Interictal 123I-IMZ SPECT was examined in all four patients with TSC. Results: A significant decrease in the NAA concentration and significant increases in the mIns and GABA concentrations were detected in the cortical tubers of all 4 patients. No significant difference was observed in Glu concentrations. In all of the cortical tubers detected by magnetic resonance imaging, 123I-IMZ binding was significantly decreased. Conclusions: Epileptogenesis in TSC might be caused by decreased inhibition secondary to the decrease in GABA receptors in dysplastic neurons of cortical tubers. An increase in the GABA concentration may compensate for decreased inhibition. |
Author | Harada, Masafumi Kagami, Shoji Mori, Kenji Miyazaki, Masahito Fujii, Emiko Mori, Tatsuo Toda, Yoshihiro |
Author_xml | – sequence: 1 givenname: Kenji surname: Mori fullname: Mori, Kenji email: moriken@clin.med.tokushima-u.ac.jp organization: Department of Pediatrics, Institute of Health Biosciences, University of Tokushima Graduate School, Tokushima 770-8503, Japan – sequence: 2 givenname: Tatsuo surname: Mori fullname: Mori, Tatsuo organization: Department of Pediatrics, Institute of Health Biosciences, University of Tokushima Graduate School, Tokushima 770-8503, Japan – sequence: 3 givenname: Yoshihiro surname: Toda fullname: Toda, Yoshihiro organization: Department of Pediatrics, Institute of Health Biosciences, University of Tokushima Graduate School, Tokushima 770-8503, Japan – sequence: 4 givenname: Emiko surname: Fujii fullname: Fujii, Emiko organization: Department of Pediatrics, Institute of Health Biosciences, University of Tokushima Graduate School, Tokushima 770-8503, Japan – sequence: 5 givenname: Masahito surname: Miyazaki fullname: Miyazaki, Masahito organization: Department of Pediatrics, Institute of Health Biosciences, University of Tokushima Graduate School, Tokushima 770-8503, Japan – sequence: 6 givenname: Masafumi surname: Harada fullname: Harada, Masafumi organization: Department of Radiology, Institute of Health Biosciences, University of Tokushima Graduate School, Tokushima 770-8503, Japan – sequence: 7 givenname: Shoji surname: Kagami fullname: Kagami, Shoji organization: Department of Pediatrics, Institute of Health Biosciences, University of Tokushima Graduate School, Tokushima 770-8503, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21959128$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkkFv1DAQhS1URLeFv1DlyCVhJnGcWEKIbYGCVIkDcLYcZ1by1usEO1nR_noctnvpgfbkkfW95_G8OWMnfvDE2AVCgYDi3bbogra-p31RAmIBsgDAF2yFbVPmDVZ4wlZQtU3eCOCn7CzGLSSiRHjFTkuUtcSyXbHbT2QC6Uh91pG_H3qr72m0nrJAhsZpCJn2fWb9kbpeX64zR3ty6TIzQ5is0S6b5o5CXK7-VcMcs2hcKqKNidqNjv68Zi832kV683Ces19fPv-8-prffL_-drW-yY0AnPK6r7FuejJcSmqEFJUE3nKJEiSRrpCI9xyhkaLeQCeFBmGgrqg0zUYir87Z24PvGIbfM8VJ7Ww05Jz2lBpTCBVvsWl5-wwU65LXNYeEXjygc7ejXo3B7nS4U8dZJuD9ATDp1zHQRhk76ckOfkpRueS12Am1Vcfo1BKdAqlSMEkuHsmPLzwp_HgQUprp3lJQ0VjyhnqbMpxUP9inLT48sjDO-iXYW7qjuB3m4FNiClUsFagfy2Ite4UIUPK2_b_Bczr4C2--4KQ |
CitedBy_id | crossref_primary_10_1007_s40263_014_0223_x crossref_primary_10_1016_j_ijdevneu_2013_02_008 crossref_primary_10_1016_j_pediatrneurol_2014_04_028 crossref_primary_10_1053_j_semnuclmed_2016_09_008 crossref_primary_10_1016_j_seizure_2021_06_028 crossref_primary_10_3390_genes13040671 crossref_primary_10_3390_cells10010134 crossref_primary_10_1039_C7CC06211G crossref_primary_10_1152_physrev_00038_2014 crossref_primary_10_2147_NDT_S347327 crossref_primary_10_1039_C7RA11860K crossref_primary_10_3389_fncel_2024_1486315 crossref_primary_10_1111_ejn_13595 crossref_primary_10_1148_rg_240062 crossref_primary_10_3390_diagnostics10121049 crossref_primary_10_3389_fnins_2022_879451 crossref_primary_10_1016_j_neuron_2013_03_017 crossref_primary_10_1016_j_braindev_2024_104314 crossref_primary_10_1186_s13041_019_0427_6 crossref_primary_10_2217_fnl_13_37 crossref_primary_10_2967_jnumed_113_129593 crossref_primary_10_1002_epi4_12253 |
Cites_doi | 10.1177/7010.2006.00242 10.1212/WNL.0b013e3181ce5d9e 10.1111/j.1528-1167.2005.01030.x 10.1080/02841859809172211 10.1177/088307389801301206 10.1001/archneur.60.11.1580 10.1016/j.pneurobio.2004.03.009 10.1034/j.1600-0404.2000.102003175.x 10.1212/WNL.40.6.985 10.1016/j.eplepsyres.2007.02.002 10.1111/j.1471-4159.1993.tb03283.x 10.1016/0092-8674(93)90618-Z 10.1177/088307380502000609 10.1126/science.277.5327.805 10.1177/08830738050200050701 10.1038/nrn920 10.1097/01.mnm.0000243380.79872.32 10.1016/0730-725X(95)02033-P 10.1002/1531-8249(200101)49:1<67::AID-ANA10>3.0.CO;2-L 10.1055/s-2007-973750 10.1016/S0920-1211(99)00011-X 10.1016/S0387-7604(01)00290-X 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J 10.1016/0140-6736(93)90754-5 10.1097/00003072-199702000-00017 10.1016/j.neuroscience.2006.11.041 10.1007/s10803-010-1065-0 |
ContentType | Journal Article |
Copyright | 2011 The Japanese Society of Child Neurology The Japanese Society of Child Neurology Copyright © 2011 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2011 The Japanese Society of Child Neurology – notice: The Japanese Society of Child Neurology – notice: Copyright © 2011 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7TK |
DOI | 10.1016/j.braindev.2011.09.001 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Neurosciences Abstracts |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic Neurosciences Abstracts |
DatabaseTitleList | MEDLINE - Academic MEDLINE Neurosciences Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1872-7131 |
EndPage | 486 |
ExternalDocumentID | 21959128 10_1016_j_braindev_2011_09_001 S0387760411002488 1_s2_0_S0387760411002488 |
Genre | Journal Article |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 23N 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 6J9 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXLA AAXUO AAYWO ABBQC ABCQJ ABFNM ABFRF ABIVO ABJNI ABMAC ABMZM ABTEW ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACIUM ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGWIK AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRLJ AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDW HMK HMO HMQ HVGLF HZ~ IHE J1W KOM LX8 M29 M2V M41 MO0 MOBAO N9A O-L O9- OAUVE OP~ OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SNS SPCBC SSH SSN SSZ T5K UNMZH WUQ X7M Z5R ZGI ~G- AACTN AFCTW AFKWA AJOXV AMFUW RIG AADPK AAIAV ABLVK ABYKQ AHPSJ AJBFU EFLBG LCYCR AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 7TK |
ID | FETCH-LOGICAL-c601t-5d5157dec499e769639048491909eea31ee4d4107965f0b96a06c053e2c7f9143 |
IEDL.DBID | .~1 |
ISSN | 0387-7604 1872-7131 |
IngestDate | Fri Jul 11 10:31:21 EDT 2025 Fri Jul 11 07:26:39 EDT 2025 Thu Apr 03 07:02:07 EDT 2025 Tue Jul 01 03:19:28 EDT 2025 Thu Apr 24 22:53:29 EDT 2025 Fri Feb 23 02:12:17 EST 2024 Sun Feb 23 10:19:22 EST 2025 Tue Aug 26 16:32:39 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | Tuberous sclerosis GABA Glutamate Proton MRS Iomazenil SPECT |
Language | English |
License | Copyright © 2011 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c601t-5d5157dec499e769639048491909eea31ee4d4107965f0b96a06c053e2c7f9143 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
PMID | 21959128 |
PQID | 1015245540 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_1034817848 proquest_miscellaneous_1015245540 pubmed_primary_21959128 crossref_citationtrail_10_1016_j_braindev_2011_09_001 crossref_primary_10_1016_j_braindev_2011_09_001 elsevier_sciencedirect_doi_10_1016_j_braindev_2011_09_001 elsevier_clinicalkeyesjournals_1_s2_0_S0387760411002488 elsevier_clinicalkey_doi_10_1016_j_braindev_2011_09_001 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2012-06-01 |
PublicationDateYYYYMMDD | 2012-06-01 |
PublicationDate_xml | – month: 06 year: 2012 text: 2012-06-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Brain & development (Tokyo. 1979) |
PublicationTitleAlternate | Brain Dev |
PublicationYear | 2012 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Barkovich, Kuzniecky, Dobyns, Jackson, Becker, Evrard (b0050) 1996; 27 van Slegtenhorst, de Hoogt, Hermans, Nellist, Janssen, Verhoef (b0060) 1997; 277 Kaneko, Sasaki, Morioka, Koga, Abe, Sawamoto (b0045) 2006; 27 Ben-Ari (b0135) 2002; 3 Aronica, Boer, Redeker, Spliet, van Rijen, Troost (b0140) 2007; 145 Morimoto, Tamagami, Matsuda (b0040) 2005; 46 Yapici, Dincer, Eraksoy (b0080) 2005; 20 Curatolo, Verdecchia, Bombardieri (b0025) 2001; 23 Harada, Taki, Nose, Kubo, Mori, Nishitani (b0030) 2011; 41 Matthews, Andermann, Arnold (b0085) 1990; 40 European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993;75:1305–15. During, Spencer (b0095) 1993; 341 Simister, McLean, Barker, Duncan (b0110) 2007; 74 Jansen, Braun, van Nieuwenhuizen, Huiskamp, Vincken, van Huffelen (b0010) 2003; 60 Roach, Gomez, Northrup (b0005) 1998; 13 Mescher, Merkle, Kirsh, Garwood, Gruetter (b0035) 1998; 11 Kälviäinen, Halonen, Pitkänen, Reikkinen (b0090) 1993; 60 Morimoto, Fahnestock, Racine (b0105) 2004; 73 Griffiths, Bolton, Verity (b0065) 1998; 39 Mizuno, Takahashi, Kato, Goto, Kondo, Hoshi (b0070) 2000; 102 Valencia, Legido, Yelin, Khurana, Kothare, Katsetos (b0120) 2006; 21 Fujita, Hashikawa, Nagai, Kodaka, Uehara, Nishimura (b0125) 1997; 22 White, Hua, Scheithauer, Lynch, Henske, Crino (b0130) 2001; 49 Mukonoweshuro, Wilkinson, Griffiths (b0075) 2001; 22 Petroff, Pleban, Spencer (b0100) 1995; 13 Wu, Salamon, Kirsch, Mantle, Nagarajan, Kurelowech (b0020) 2010; 74 Aasly, Silfvenius, Aas, Sonnewald, Olivecrona, Juul (b0115) 1999; 35 Kagawa, Chugani, Asano, Juhász, Muzik, Shah (b0015) 2005; 20 Roach (10.1016/j.braindev.2011.09.001_b0005) 1998; 13 van Slegtenhorst (10.1016/j.braindev.2011.09.001_b0060) 1997; 277 Matthews (10.1016/j.braindev.2011.09.001_b0085) 1990; 40 Wu (10.1016/j.braindev.2011.09.001_b0020) 2010; 74 Simister (10.1016/j.braindev.2011.09.001_b0110) 2007; 74 Yapici (10.1016/j.braindev.2011.09.001_b0080) 2005; 20 Petroff (10.1016/j.braindev.2011.09.001_b0100) 1995; 13 Barkovich (10.1016/j.braindev.2011.09.001_b0050) 1996; 27 Aronica (10.1016/j.braindev.2011.09.001_b0140) 2007; 145 Valencia (10.1016/j.braindev.2011.09.001_b0120) 2006; 21 Morimoto (10.1016/j.braindev.2011.09.001_b0040) 2005; 46 White (10.1016/j.braindev.2011.09.001_b0130) 2001; 49 Aasly (10.1016/j.braindev.2011.09.001_b0115) 1999; 35 Harada (10.1016/j.braindev.2011.09.001_b0030) 2011; 41 Mukonoweshuro (10.1016/j.braindev.2011.09.001_b0075) 2001; 22 10.1016/j.braindev.2011.09.001_b0055 Mizuno (10.1016/j.braindev.2011.09.001_b0070) 2000; 102 Kagawa (10.1016/j.braindev.2011.09.001_b0015) 2005; 20 Kaneko (10.1016/j.braindev.2011.09.001_b0045) 2006; 27 Mescher (10.1016/j.braindev.2011.09.001_b0035) 1998; 11 During (10.1016/j.braindev.2011.09.001_b0095) 1993; 341 Curatolo (10.1016/j.braindev.2011.09.001_b0025) 2001; 23 Morimoto (10.1016/j.braindev.2011.09.001_b0105) 2004; 73 Fujita (10.1016/j.braindev.2011.09.001_b0125) 1997; 22 Jansen (10.1016/j.braindev.2011.09.001_b0010) 2003; 60 Griffiths (10.1016/j.braindev.2011.09.001_b0065) 1998; 39 Ben-Ari (10.1016/j.braindev.2011.09.001_b0135) 2002; 3 Kälviäinen (10.1016/j.braindev.2011.09.001_b0090) 1993; 60 |
References_xml | – volume: 27 start-page: 59 year: 1996 end-page: 63 ident: b0050 article-title: A classification scheme for malformations of cortical development publication-title: Neuropediatrics – volume: 60 start-page: 1580 year: 2003 end-page: 1584 ident: b0010 article-title: Diffusion-weighted magnetic resonance imaging and identification of the epileptogenic tuber in patients with tuberous sclerosis publication-title: Arch Neurol – volume: 74 start-page: 107 year: 2007 end-page: 115 ident: b0110 article-title: Proton magnetic resonance spectroscopy of malformations of cortical development causing epilepsy publication-title: Epilepsy Res – volume: 22 start-page: 130 year: 1997 end-page: 131 ident: b0125 article-title: Decrease of the central type benzodiazepine receptor in cortical tubers in a patient with tuberous sclerosis publication-title: Clin Nucl Med – volume: 40 start-page: 985 year: 1990 end-page: 989 ident: b0085 article-title: A proton magnetic resonance spectroscopy study of focal epilepsy in humans publication-title: Neurology – volume: 11 start-page: 266 year: 1998 end-page: 272 ident: b0035 article-title: Simultaneous in vivo spectral editing and water suppression publication-title: NMR Biomed – volume: 46 start-page: 184 year: 2005 end-page: 188 ident: b0040 article-title: Central-type benzodiazepine receptors and epileptogenesis: basic mechanisms and clinical validity publication-title: Epilepsia – volume: 145 start-page: 185 year: 2007 end-page: 196 ident: b0140 article-title: Differential expression patterns of chloride transporters, Na publication-title: Neuroscience – volume: 13 start-page: 624 year: 1998 end-page: 628 ident: b0005 article-title: Tuberous sclerosis complex consensus conference. Revised clinical diagnostic criteria publication-title: J Child Neurol – volume: 20 start-page: 429 year: 2005 end-page: 438 ident: b0015 article-title: Epilepsy surgery outcome in children with tuberous sclerosis complex evaluated with alpha-[11C]methyl- publication-title: J Child Neurol – volume: 341 start-page: 1607 year: 1993 end-page: 1610 ident: b0095 article-title: Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain publication-title: Lancet – volume: 39 start-page: 482 year: 1998 end-page: 486 ident: b0065 article-title: White matter abnormalities in tuberous sclerosis complex publication-title: Acta Radiol – volume: 35 start-page: 211 year: 1999 end-page: 217 ident: b0115 article-title: Proton magnetic resonance spectroscopy of brain biopsies from patients with intractable epilepsy publication-title: Epilepsy Res – reference: European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993;75:1305–15. – volume: 20 start-page: 517 year: 2005 end-page: 522 ident: b0080 article-title: Proton spectroscopic findings in children with epilepsy owing to tuberous sclerosis complex publication-title: J Child Neurol – volume: 22 start-page: 1920 year: 2001 end-page: 1925 ident: b0075 article-title: Proton MR spectroscopy of cortical tubers in adults with tuberous sclerosis complex publication-title: Am J Neuroradiol – volume: 27 start-page: 893 year: 2006 end-page: 899 ident: b0045 article-title: Pre-surgical identification of epileptogenic areas in temporal lobe epilepsy by 123I-iomazenil SPECT: a comparison with IMP SPECT and FDG PET publication-title: Nucl Med Commun – volume: 74 start-page: 392 year: 2010 end-page: 398 ident: b0020 article-title: Noninvasive testing, early surgery, and seizure freedom in tuberous sclerosis complex publication-title: Neurology – volume: 277 start-page: 805 year: 1997 end-page: 808 ident: b0060 article-title: Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34 publication-title: Science – volume: 13 start-page: 1197 year: 1995 end-page: 1211 ident: b0100 article-title: Symbiosis between in vivo and in vitro NMR spectroscopy: the creatine, N-acetylaspartate, glutamate, and GABA content of the epileptic human brain publication-title: Magn Reson Imaging – volume: 41 start-page: 447 year: 2011 end-page: 454 ident: b0030 article-title: Non-invasive evaluation of the GABAergic/glutamatergic system in autistic patients observed by MEGA-editing proton MR spectroscopy using a clinical 3 tesla instrument publication-title: J Autism Dev Disord – volume: 3 start-page: 728 year: 2002 end-page: 739 ident: b0135 article-title: Excitatory actions of GABA during development: the nature of the nurture publication-title: Nat Rev Neurosci – volume: 23 start-page: 649 year: 2001 end-page: 653 ident: b0025 article-title: Vigabatrin for tuberous sclerosis complex publication-title: Brain Dev – volume: 21 start-page: 1058 year: 2006 end-page: 1063 ident: b0120 article-title: Anomalous inhibitory circuits in cortical tubers of human tuberous sclerosis complex associated with refractory epilepsy: aberrant expression of parvalbumin and calbindin-D28k in dysplastic cortex publication-title: J Child Neurol – volume: 73 start-page: 1 year: 2004 end-page: 60 ident: b0105 article-title: Kindling and status epilepticus models of epilepsy: rewiring the brain publication-title: Prog Neurobiol – volume: 102 start-page: 175 year: 2000 end-page: 178 ident: b0070 article-title: Magnetic resonance spectroscopy of tubers in patients with tuberous sclerosis publication-title: Acta Neurol Scand – volume: 60 start-page: 1244 year: 1993 end-page: 1250 ident: b0090 article-title: Amino acid levels in the cerebrospinal fluid of newly diagnosed epileptic patients: effect of vigabatrin and carbamazepine monotherapies publication-title: J Neurochem – volume: 49 start-page: 67 year: 2001 end-page: 78 ident: b0130 article-title: Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers publication-title: Ann Neurol – volume: 21 start-page: 1058 year: 2006 ident: 10.1016/j.braindev.2011.09.001_b0120 article-title: Anomalous inhibitory circuits in cortical tubers of human tuberous sclerosis complex associated with refractory epilepsy: aberrant expression of parvalbumin and calbindin-D28k in dysplastic cortex publication-title: J Child Neurol doi: 10.1177/7010.2006.00242 – volume: 74 start-page: 392 year: 2010 ident: 10.1016/j.braindev.2011.09.001_b0020 article-title: Noninvasive testing, early surgery, and seizure freedom in tuberous sclerosis complex publication-title: Neurology doi: 10.1212/WNL.0b013e3181ce5d9e – volume: 46 start-page: 184 issue: suppl 5 year: 2005 ident: 10.1016/j.braindev.2011.09.001_b0040 article-title: Central-type benzodiazepine receptors and epileptogenesis: basic mechanisms and clinical validity publication-title: Epilepsia doi: 10.1111/j.1528-1167.2005.01030.x – volume: 39 start-page: 482 year: 1998 ident: 10.1016/j.braindev.2011.09.001_b0065 article-title: White matter abnormalities in tuberous sclerosis complex publication-title: Acta Radiol doi: 10.1080/02841859809172211 – volume: 13 start-page: 624 year: 1998 ident: 10.1016/j.braindev.2011.09.001_b0005 article-title: Tuberous sclerosis complex consensus conference. Revised clinical diagnostic criteria publication-title: J Child Neurol doi: 10.1177/088307389801301206 – volume: 60 start-page: 1580 year: 2003 ident: 10.1016/j.braindev.2011.09.001_b0010 article-title: Diffusion-weighted magnetic resonance imaging and identification of the epileptogenic tuber in patients with tuberous sclerosis publication-title: Arch Neurol doi: 10.1001/archneur.60.11.1580 – volume: 73 start-page: 1 year: 2004 ident: 10.1016/j.braindev.2011.09.001_b0105 article-title: Kindling and status epilepticus models of epilepsy: rewiring the brain publication-title: Prog Neurobiol doi: 10.1016/j.pneurobio.2004.03.009 – volume: 102 start-page: 175 year: 2000 ident: 10.1016/j.braindev.2011.09.001_b0070 article-title: Magnetic resonance spectroscopy of tubers in patients with tuberous sclerosis publication-title: Acta Neurol Scand doi: 10.1034/j.1600-0404.2000.102003175.x – volume: 40 start-page: 985 year: 1990 ident: 10.1016/j.braindev.2011.09.001_b0085 article-title: A proton magnetic resonance spectroscopy study of focal epilepsy in humans publication-title: Neurology doi: 10.1212/WNL.40.6.985 – volume: 74 start-page: 107 year: 2007 ident: 10.1016/j.braindev.2011.09.001_b0110 article-title: Proton magnetic resonance spectroscopy of malformations of cortical development causing epilepsy publication-title: Epilepsy Res doi: 10.1016/j.eplepsyres.2007.02.002 – volume: 60 start-page: 1244 year: 1993 ident: 10.1016/j.braindev.2011.09.001_b0090 article-title: Amino acid levels in the cerebrospinal fluid of newly diagnosed epileptic patients: effect of vigabatrin and carbamazepine monotherapies publication-title: J Neurochem doi: 10.1111/j.1471-4159.1993.tb03283.x – ident: 10.1016/j.braindev.2011.09.001_b0055 doi: 10.1016/0092-8674(93)90618-Z – volume: 20 start-page: 517 year: 2005 ident: 10.1016/j.braindev.2011.09.001_b0080 article-title: Proton spectroscopic findings in children with epilepsy owing to tuberous sclerosis complex publication-title: J Child Neurol doi: 10.1177/088307380502000609 – volume: 277 start-page: 805 year: 1997 ident: 10.1016/j.braindev.2011.09.001_b0060 article-title: Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34 publication-title: Science doi: 10.1126/science.277.5327.805 – volume: 20 start-page: 429 year: 2005 ident: 10.1016/j.braindev.2011.09.001_b0015 article-title: Epilepsy surgery outcome in children with tuberous sclerosis complex evaluated with alpha-[11C]methyl-l-tryptophan positron emission tomography (PET) publication-title: J Child Neurol doi: 10.1177/08830738050200050701 – volume: 3 start-page: 728 year: 2002 ident: 10.1016/j.braindev.2011.09.001_b0135 article-title: Excitatory actions of GABA during development: the nature of the nurture publication-title: Nat Rev Neurosci doi: 10.1038/nrn920 – volume: 27 start-page: 893 year: 2006 ident: 10.1016/j.braindev.2011.09.001_b0045 article-title: Pre-surgical identification of epileptogenic areas in temporal lobe epilepsy by 123I-iomazenil SPECT: a comparison with IMP SPECT and FDG PET publication-title: Nucl Med Commun doi: 10.1097/01.mnm.0000243380.79872.32 – volume: 13 start-page: 1197 year: 1995 ident: 10.1016/j.braindev.2011.09.001_b0100 article-title: Symbiosis between in vivo and in vitro NMR spectroscopy: the creatine, N-acetylaspartate, glutamate, and GABA content of the epileptic human brain publication-title: Magn Reson Imaging doi: 10.1016/0730-725X(95)02033-P – volume: 22 start-page: 1920 year: 2001 ident: 10.1016/j.braindev.2011.09.001_b0075 article-title: Proton MR spectroscopy of cortical tubers in adults with tuberous sclerosis complex publication-title: Am J Neuroradiol – volume: 49 start-page: 67 year: 2001 ident: 10.1016/j.braindev.2011.09.001_b0130 article-title: Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers publication-title: Ann Neurol doi: 10.1002/1531-8249(200101)49:1<67::AID-ANA10>3.0.CO;2-L – volume: 27 start-page: 59 year: 1996 ident: 10.1016/j.braindev.2011.09.001_b0050 article-title: A classification scheme for malformations of cortical development publication-title: Neuropediatrics doi: 10.1055/s-2007-973750 – volume: 35 start-page: 211 year: 1999 ident: 10.1016/j.braindev.2011.09.001_b0115 article-title: Proton magnetic resonance spectroscopy of brain biopsies from patients with intractable epilepsy publication-title: Epilepsy Res doi: 10.1016/S0920-1211(99)00011-X – volume: 23 start-page: 649 year: 2001 ident: 10.1016/j.braindev.2011.09.001_b0025 article-title: Vigabatrin for tuberous sclerosis complex publication-title: Brain Dev doi: 10.1016/S0387-7604(01)00290-X – volume: 11 start-page: 266 year: 1998 ident: 10.1016/j.braindev.2011.09.001_b0035 article-title: Simultaneous in vivo spectral editing and water suppression publication-title: NMR Biomed doi: 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J – volume: 341 start-page: 1607 year: 1993 ident: 10.1016/j.braindev.2011.09.001_b0095 article-title: Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain publication-title: Lancet doi: 10.1016/0140-6736(93)90754-5 – volume: 22 start-page: 130 year: 1997 ident: 10.1016/j.braindev.2011.09.001_b0125 article-title: Decrease of the central type benzodiazepine receptor in cortical tubers in a patient with tuberous sclerosis publication-title: Clin Nucl Med doi: 10.1097/00003072-199702000-00017 – volume: 145 start-page: 185 year: 2007 ident: 10.1016/j.braindev.2011.09.001_b0140 article-title: Differential expression patterns of chloride transporters, Na+–K+–2Cl−-cotransporter and K+–Cl−-cotransporter, in epilepsy-associated malformations of cortical development publication-title: Neuroscience doi: 10.1016/j.neuroscience.2006.11.041 – volume: 41 start-page: 447 year: 2011 ident: 10.1016/j.braindev.2011.09.001_b0030 article-title: Non-invasive evaluation of the GABAergic/glutamatergic system in autistic patients observed by MEGA-editing proton MR spectroscopy using a clinical 3 tesla instrument publication-title: J Autism Dev Disord doi: 10.1007/s10803-010-1065-0 |
SSID | ssj0001210 |
Score | 2.1044748 |
Snippet | To elucidate the functional characteristics of cortical tubers that might be responsible for epilepsy in tuberous sclerosis complex (TSC), proton magnetic... Abstract Purpose To elucidate the functional characteristics of cortical tubers that might be responsible for epilepsy in tuberous sclerosis complex (TSC),... Purpose: To elucidate the functional characteristics of cortical tubers that might be responsible for epilepsy in tuberous sclerosis complex (TSC), proton... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 478 |
SubjectTerms | Aspartic Acid - analogs & derivatives Aspartic Acid - metabolism Benzodiazepine receptors Brain Brain - diagnostic imaging Brain - metabolism Case-Control Studies Child Child, Preschool Children Cortex Epilepsy Female Flumazenil - analogs & derivatives GABA gamma -Aminobutyric acid gamma -Aminobutyric acid receptors gamma-Aminobutyric Acid - metabolism Glutamate Glutamic acid Glutamic Acid - metabolism Humans Inositol - metabolism Iodine Radioisotopes Iomazenil SPECT Magnetic resonance imaging Magnetic Resonance Spectroscopy Male N-Acetylaspartate Neurology Parietal lobe Proton MRS Protons Radiopharmaceuticals Receptors, GABA-A - metabolism Single photon emission computed tomography Spectroscopy Steam Temporal lobe Tomography, Emission-Computed, Single-Photon Tuberous sclerosis Tuberous Sclerosis - diagnostic imaging Tuberous Sclerosis - metabolism |
Title | Decreased benzodiazepine receptor and increased GABA level in cortical tubers in tuberous sclerosis complex |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0387760411002488 https://www.clinicalkey.es/playcontent/1-s2.0-S0387760411002488 https://dx.doi.org/10.1016/j.braindev.2011.09.001 https://www.ncbi.nlm.nih.gov/pubmed/21959128 https://www.proquest.com/docview/1015245540 https://www.proquest.com/docview/1034817848 |
Volume | 34 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELaqIiEuqLyXR2UkrukmXidZH5dCWUD0ApV6sxJ7Im1bZVdkt0I98Nv5xnEWECoguCWOR5mMZ-xv4pmxEC-cn1BWNzWcnCkcFK8oqarGJZlxlSuw3pMP0RbHxfxEvzvNT3fE4ZALw2GVce7v5_QwW8eWcZTmeLVYjD_yxmtZpJqLninoIWew65K1_ODr9zAPLpAVdhJgTNz7hyzhs4Oaj2HwdBlLeYbSldctUNcB0LAQHe2J2xFBylnP5B2xQ-1dcfND3CO_J85fBSTYkZc1tVdLKMAVrfBI4kNpBR9bVq2Xi3bo9Wb2ciYvOHgIjRLeaPi9LdebGtCQm8LVctPJDi8E04tOhkh0-nJfnBy9_nQ4T-KRComD57VOcg_8UnpycHSoLGB9BiasDWCBIaomGZH2Gi6hKfImrU1RpYWDnZJyZWOArR6I3XbZ0iMhfYqh9N5XmfO6mSrjaj1RnJEEDKSyaiTyQY7WxXrjfOzFhR0Cy87sIH_L8rep4Qi7kRhv6VZ9xY0_UpTDMNkhnxQzoMWi8G-U1EVD7mxmO2VT-4uyjYTZUv6kr3_11ueDLlkYM-_QVC1hGJkoVxoIL_1dH86dLqcaPDzsFXErJ8WlgoA4Hv8Hd0_ELdypPhzuqdhdf97QMwCvdb0fLGtf3Ji9fT8__gajZC1z |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED-NTgJeEJ-jfBqJ19DEdZL6sQxGx7a-sEl7sxz7InVMaUVahPbXc-c4FQgNELxFjk92znfn38V3Z4DXzo8xq-qKnJwJOSheYmJt7ZJMO-sK2u_Rh2iLeTE7Ux_P8_Md2O9zYTisMtr-zqYHax1bRpGbo9ViMfrEB69lkSoueiZJDm_ALlenygewOz08ms23BplrZIXDBNInJvghUfjiTcU3MXj8Gqt5huqV1-1R12HQsBcd3IU7EUSKaTfPe7CDzX24eRKPyR_A53cBDLboRYXN1ZJk4ApX9ErQt-KK3GxhGy8WTd_rw_TtVFxy_BA1CnJIwx9usd5UhA65KTwtN61oaUCa9KIVIRgdvz2Es4P3p_uzJN6qkDhyvtZJ7gnClB4d-TpYFqSAmrRYaUIGGtGOM0TlFXmFusjrtNKFTQtHqorSlbUmePUIBs2ywccgfEqr6b23mfOqnkjtKjWWnJREMEhmdgh5z0fjYslxvvni0vSxZRem579h_ptUc5DdEEZbulVXdOOPFGW_TKZPKSUjaGhf-DdKbKMutyYzrTSp-UXehqC3lD-J7F-N-qqXJUP6zIc0tkFaRibKpSKQl_6uD6dPlxNFc9jrBHHLJ8nVggh0PPmP2b2EW7PTk2NzfDg_egq36Y3souOewWD9ZYPPCYetqxdRz74D32IwJA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Decreased+benzodiazepine+receptor+and+increased+GABA+level+in+cortical+tubers+in+tuberous+sclerosis+complex&rft.jtitle=Brain+%26+development+%28Tokyo.+1979%29&rft.au=Mori%2C+Kenji&rft.au=Mori%2C+Tatsuo&rft.au=Toda%2C+Yoshihiro&rft.au=Fujii%2C+Emiko&rft.date=2012-06-01&rft.pub=Elsevier+B.V&rft.issn=0387-7604&rft.volume=34&rft.issue=6&rft.spage=478&rft.epage=486&rft_id=info:doi/10.1016%2Fj.braindev.2011.09.001&rft.externalDocID=S0387760411002488 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F03877604%2FS0387760412X00056%2Fcov150h.gif |